Ka
Kartos
Redwood City CAFounded 201840 employees
Private CapbiotechPrivateHematology
Platform: Myelofibrosis
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KAR-5490 | KAR-5490 | Phase 1 | 1 | RET | EpilepsyRSV | ||
| KAR-9558 | KAR-9558 | Approved | 3 | USP1 | HS | ||
| KAR-2338 | KAR-2338 | Preclinical | 1 | DLL3 | CRC | ||
| KAR-4449 | KAR-4449 | Phase 2 | 2 | MET | MCLBreast Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)